TCTR20210227001招募中4 期
Clinical outcome in treatment of MDR A.baumannii pneumonia treated with colistin combined with high dose sulbactam : A randomized control trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 152
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. A. baumannii MDR pneumonia patients
- •2. Age 18 or over 18 years old
排除标准
- •1. Sputum culture shows mixed organisms
- •2. Concurrent or coinfection with other organs
- •3. Not received colistin for empirical treatment
- •4. Receive colistin >6 calendar days before date of collected sputum
- •5. Allergy to colistin or sulbactam
- •6. Previous participated in this trial within 14 days
- •7. Pregnancy
研究者
相似试验
已完成
4 期
A randomized controlled trial of colistin combined with sulbactam: 9 g per day versus 12 g per day in the treatment of extensively drug-resistant resistant Acinetobacter baumannii pneumoniaExtensively drug resistance Acinetobacter baumannii pneumoniaXDR A. baumannii, colistin, high dose sulbactamTCTR20190623002Department of Medicine, Phramongkutklao Hospital138
招募中
不适用
Clinical pathological study in patients with barnacle-like gastric lesionsbarnacle gastric lesionJPRN-UMIN000044109Kawasaki Medical School200
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-CZAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-HUAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossIdiopathic sudden sensorineural hearing lossMedDRA version: 19.1Level: PTClassification code 10043882Term: TinnitusSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2013-002077-21-DEAuris Medical AG255